Literature DB >> 22475506

PDE inhibition and cognition enhancement.

Arjan Blokland, Frank S Menniti, Jos Prickaerts.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22475506     DOI： 10.1517/13543776.2012.674514

Source DB:  PubMed          Journal:  Expert Opin Ther Pat        ISSN： 1354-3776            Impact factor:   6.674


× No keyword cloud information.
  15 in total

Review 1.  Advances in targeting cyclic nucleotide phosphodiesterases.

Authors:  Donald H Maurice; Hengming Ke; Faiyaz Ahmad; Yousheng Wang; Jay Chung; Vincent C Manganiello
Journal:  Nat Rev Drug Discov       Date:  2014-04       Impact factor: 84.694

Review 2.  PDE4 as a target for cognition enhancement.

Authors:  Wito Richter; Frank S Menniti; Han-Ting Zhang; Marco Conti
Journal:  Expert Opin Ther Targets       Date:  2013-07-25       Impact factor: 6.902

3.  Structure-Based Design of a Potent, Selective, and Brain Penetrating PDE2 Inhibitor with Demonstrated Target Engagement.

Authors:  Peter Buijnsters; Meri De Angelis; Xavier Langlois; Frederik J R Rombouts; Wendy Sanderson; Gary Tresadern; Alison Ritchie; Andrés A Trabanco; Greet VanHoof; Yves Van Roosbroeck; José-Ignacio Andrés
Journal:  ACS Med Chem Lett       Date:  2014-07-22       Impact factor: 4.345

Review 4.  Clinical and molecular genetics of the phosphodiesterases (PDEs).

Authors:  Monalisa F Azevedo; Fabio R Faucz; Eirini Bimpaki; Anelia Horvath; Isaac Levy; Rodrigo B de Alexandre; Faiyaz Ahmad; Vincent Manganiello; Constantine A Stratakis
Journal:  Endocr Rev       Date:  2013-12-05       Impact factor: 19.871

Review 5.  Pharmacological modulation of phosphodiesterase-7 as a novel strategy for neurodegenerative disorders.

Authors:  Heena Khan; Chanchal Tiwari; Amarjot Kaur Grewal; Thakur Gurjeet Singh; Simran Chauhan; Gaber El-Saber Batiha
Journal:  Inflammopharmacology       Date:  2022-10-22       Impact factor: 5.093

Review 6.  Cyclic nucleotide phosphodiesterases: important signaling modulators and therapeutic targets.

Authors:  F Ahmad; T Murata; K Shimizu; E Degerman; D Maurice; V Manganiello
Journal:  Oral Dis       Date:  2014-09-12       Impact factor: 3.511

7.  Enhancement of memories by systemic administration of insulin-like growth factor II.

Authors:  Sarah A Stern; Amy S Kohtz; Gabriella Pollonini; Cristina M Alberini
Journal:  Neuropsychopharmacology       Date:  2014-03-19       Impact factor: 7.853

8.  Proof-of-Concept Randomized Controlled Study of Cognition Effects of the Proprietary Extract Sceletium tortuosum (Zembrin) Targeting Phosphodiesterase-4 in Cognitively Healthy Subjects: Implications for Alzheimer's Dementia.

Authors:  Simon Chiu; Nigel Gericke; Michel Farina-Woodbury; Vladimir Badmaev; Hana Raheb; Kristen Terpstra; Joalex Antongiorgi; Yves Bureau; Zack Cernovsky; Jirui Hou; Veronica Sanchez; Marissa Williams; John Copen; Mariwan Husni; Liz Goble
Journal:  Evid Based Complement Alternat Med       Date:  2014-10-19       Impact factor: 2.629

Review 9.  Targeting phosphodiesterase 4 as a potential therapeutic strategy for enhancing neuroplasticity following ischemic stroke.

Authors:  Haitao Wang; Uma Gaur; Jiao Xiao; Bingtian Xu; Jiangping Xu; Wenhua Zheng
Journal:  Int J Biol Sci       Date:  2018-10-03       Impact factor: 6.580

Review 10.  Targeting Phosphodiesterases-Towards a Tailor-Made Approach in Multiple Sclerosis Treatment.

Authors:  Melissa Schepers; Assia Tiane; Dean Paes; Selien Sanchez; Ben Rombaut; Elisabeth Piccart; Bart P F Rutten; Bert Brône; Niels Hellings; Jos Prickaerts; Tim Vanmierlo
Journal:  Front Immunol       Date:  2019-07-24       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.